Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

13.0%

3 terminated/withdrawn out of 23 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

17%

4 trials in Phase 3/4

Results Transparency

39%

7 of 18 completed trials have results

Key Signals

7 with results

Enrollment Performance

Analytics

N/A

7(58.3%)

Phase 4

4(33.3%)

Phase 1

1(8.3%)

12Total

N/A(7)

Phase 4(4)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials

NCT03163030Not ApplicableCompleted

Autonomic Regulation Therapy in Heart Failure With Preserved Ejection Fraction

Role: lead

NCT01626599Not ApplicableCompleted

Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data

Role: lead

NCT01281293Completed

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Role: lead

NCT02385526Completed

Vagus Nerve Stimulation Titration Protocol to Improve Tolerance and Accelerate Adaptation

Role: lead

NCT02545582Suspended

VITARIA Registry Study

Role: lead

NCT01325623Not ApplicableCompleted

Seizure Detection and Automatic Magnet Mode Performance Study

Role: lead

NCT00320372Completed

Treatment-Resistant Depression Registry

Role: lead

NCT01846741Not ApplicableCompleted

VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)

Role: lead

NCT01823887Phase 1Completed

Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure (ANTHEM-HF) Study

Role: lead

NCT00522418Phase 4Terminated

Study Comparing Best Medical Practice With or Without VNS Therapy in Pharmacoresistant Partial Epilepsy Patients

Role: lead

NCT01281280Completed

PuLsE 2-Observational Long-Term Effectiveness Follow-Up Study of PuLsE 1

Role: lead

NCT01612689Not ApplicableCompleted

3-Dimensional Accelerometer Sub-Study

Role: lead

NCT01202669Completed

Heart Rate Changes in Subjects With Epilepsy

Role: lead

NCT01118455Phase 4Terminated

Trial to Assess Vagus Nerve Stimulation Therapy vs. Anti-Epileptic Drug (AED) Treatment in Children With Refractory Seizures

Role: lead

NCT00305565Phase 4Completed

Study Comparing Outcomes for Patients With Treatment Resistant Depression Who Receive VNS Therapy at Different Doses

Role: lead

NCT01486056Completed

ECG Vector Determination

Role: lead

NCT01485016Completed

Physiological and Biomechanical Data Collection Study in Epilepsy Subjects

Role: lead

NCT01214707Completed

Heart Rate Changes During Normal Activity, Exercise, and Seizures in Subjects With Epilepsy

Role: lead

NCT01202682Completed

Heart Rate Changes During Normal Activity, Exercise, and Sleep in Normal Healthy Subjects With and Without Epilepsy

Role: lead

NCT01268007Completed

Heartbeat Sensitivity Calibration Using the ECG Accessory

Role: lead